ICM
FFIV icon

Invenomic Capital Management’s F5 FFIV Stock Holding History

Invenomic Capital Management’s Portfolio FFIV Stock Details FFIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-106,825
Closed -$15.6M – 142
2023
Q1 		$15.6M Buy
106,825
+58,093
+119% +$8.39M 0.88% 38
2022
Q4 		$6.99M Buy
48,732
+27,825
+133% +$4.07M 0.47% 73
2022
Q3 		$3.03M Buy
+20,907
New +$3.31M 0.26% 102
2020
Q4 		– Sell
-13,224
Closed -$1.62M – 153
2020
Q3 		$1.62M Buy
13,224
+4,307
+48% +$579K 0.89% 41
2020
Q2 		$1.24M Sell
8,917
-2,391
-21% -$322K 0.92% 41
2020
Q1 		$1.21M Buy
+11,308
New +$1.38M 0.99% 36

Other funds holding FFIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Invenomic Capital Management's FFIV Position: Q2 2023 in Review

Invenomic Capital Management sold out of F5 (FFIV) in Q2 2023, closing a stake of 106,825 shares — an estimated $15.6M sold.

Invenomic Capital Management first reported a position in FFIV in Q1 2020 and held it in 6 quarters. The position peaked at $15.6M in Q1 2023. 497 funds tracked by Wall St. Rank hold FFIV as of Q2 2023.

  • Invenomic Capital Management reported no remaining F5 position as of Q2 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 106,825 F5 shares in Q2 2023, an estimated $15.6M.
  • Invenomic Capital Management first reported a position in F5 in Q1 2020 and held it in 6 quarters.
  • Invenomic Capital Management's F5 position peaked at $15.6M in Q1 2023.
  • 497 funds tracked by Wall St. Rank held F5 as of Q2 2023.

Based on Invenomic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.